Company description

Founded in 1995 with a vision to establish a company that would in turn help create a healthier China, Simcere Pharmaceutical Group has become a leading manufacturer and supplier of drugs in the rapidly growing China pharmaceutical market, we now have seven certified Good Manufacturing Practices ("GMP") manufacturing facilities and three research and development center and over 4,000 employees. Now Simcere has more than 20 Innovative Pharmaceuticals which are under development, and they all have independent intellectual property rights. In 2010, From them we submited five clinical trial applications to the SFDA. In 2007 Simcere successfully landed the New York Stock Exchange (ticker symbol SCR) as the first one in mainland China's chemical and biological drugs NYSE-listed company. Simcere is actively increasing our collaborations with international companies (such as Bristol-Myers Squibb Company) to develop new drugs. August 2011, Simcere signed a cooperation framework agreement with Merck to establish a company, provide patients with more high-quality drugs. Simcere has more than 20 kinds of bulk drug products have passed the GMP certification. Their preparations are saled in China for many years. The raw materials and preparations of Montmorillonite both successfully passed and received EU GMP certification. Simcere API's advantage comes from good quality. We have a very strict and continuous improvement of the quality management system. This effectively ensures verification from production equipment, raw materials, processing, semi-finished and finished product to ensure stable production process and quality. Simcere is committed to providing our customers with excellent quality products, simple and efficient service, and Simcere has been concerned with environmental, health and safety issues. We are looking forward to become a trusty cooperator in the pharmaceutical industry.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: APIs More

Recently at

18 mar 2019

CPhI Japan 2019

18 - 20 March 2019 Tokyo, Japan We were at stand 3B-34 See our Exhibitor Profile   See full Exhibitor List
12 mar 2019

CPhI South East Asia 2019

12-14 March 2019 Bangkok, Thailand We were at stand A2 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with SIMCERE PHARMACEUTICAL GROUP


Contact information




View all contact information